Physician profile
James L Warnock
NPI 1356360119
$6,317.12
in general payments reported to CMS, 2019-2025
38 companies · $823 in 2025
The $823 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,104 · 2020: $619 · 2021: $761 · 2022: $1,004 · 2023: $1,335 · 2024: $671 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,829.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,269.30 | 2019-2025 | |
| Edwards Lifesciences Corporation | $697.57 | 2021-2023 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $587.49 | 2019-2024 | Gallant |
| Alnylam Pharmaceuticals INC. | $346.86 | 2019-2025 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $337.28 | 2020-2025 | Wainua |
| Irhythm Technologies, INC. | $272.08 | 2019-2023 | Zio Xt Patch |
| E.R. Squibb & Sons, L.L.C. | $243.32 | 2019-2024 | Camzyos, Eliquis |
| Philips North America LLC | $208.26 | 2024-2025 | (Bh4) Igt Devices Undivided, (6571) Eagle Eye, Lm Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.58 | 2020-2023 | Jardiance |
| Heartflow, INC. | $194.37 | 2022-2023 | Ffrct |
| Merck Sharp & Dohme LLC | $194.28 | 2022-2025 | Verquvo |
| Pfizer INC. | $187.15 | 2019-2025 | |
| Boston Scientific Corporation | $168.15 | 2020-2025 | Watchman Access System |
| Siemens Medical Solutions USA, INC. | $164.23 | 2022-2023 | Magnetom Altea |
| Medtronic, INC. | $152.17 | 2022-2025 | Micra, Linq II |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Warnock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.